BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3258788)

  • 1. Primary lung cancer. A controlled study of preoperative and postoperative levels of circulating immune complexes.
    Bukh A; Aguado MT; Kimose HH; Mouritzen C; Møoller NP
    Cancer; 1988 May; 61(10):2033-41. PubMed ID: 3258788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
    Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
    J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of circulating immune complexes in patients with breast cancer.
    Bukh A; Aguado MT; Krarup N; Poulsen HS; Nordentoft AM; Møller NP
    Int J Cancer; 1988 Mar; 41(3):364-70. PubMed ID: 3257943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes and complement breakdown product C3d in glomerulonephritis and kidney transplantation.
    Sølling J
    Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):213-20. PubMed ID: 6391086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of serial determinations of circulating immune complex levels in malignant melanoma.
    Bukh A; Møller-Larsen A; Aguado MT; Møller-Larsen F; Møller NP
    Cancer Immunol Immunother; 1988; 26(3):280-4. PubMed ID: 3260134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lung cancer--a comparative study of the levels of circulating immune complexes in pulmonary blood draining the tumor area and peripheral venous blood.
    Bukh A; Kimose HH; Aguado MT; Linnet L; Møller NP
    Int J Cancer; 1989 May; 43(5):837-40. PubMed ID: 2714887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes and complement activation following rupture of intracranial saccular aneurysms.
    Ostergaard JR; Kristensen BO; Svehag SE; Teisner B; Miletic T
    J Neurosurg; 1987 Jun; 66(6):891-7. PubMed ID: 3494822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis.
    Olmez U; Garred P; Mollnes TE; Harboe M; Berntzen HB; Munthe E
    Scand J Rheumatol; 1991; 20(3):183-9. PubMed ID: 2068540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.
    Krauledat PB; Krapf FE; Manger B; Kalden JR
    Rheumatol Int; 1985; 5(3):97-101. PubMed ID: 3892637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
    Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
    Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and analysis of circulating immune complexes in leprosy.
    Ramanathan VD; Parkash O; Ramu G; Parker D; Curtis J; Sengupta U; Turk JL
    Clin Immunol Immunopathol; 1984 Sep; 32(3):261-8. PubMed ID: 6380842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
    Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
    J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for circulating immune complexes and activation of the complement system in relation to estrogen treatment.
    Bukh A; Jensen HK; Andersen HJ; Eriksen PB; Møller NP
    Acta Obstet Gynecol Scand; 1987; 66(8):703-8. PubMed ID: 3329440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating antigens, immune complexes and C3d levels in human schistosomiasis: relationship with Schistosoma mansoni egg output.
    Santoro F; Prata A; Castro CN; Capron A
    Clin Exp Immunol; 1980 Nov; 42(2):219-25. PubMed ID: 7471514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.